PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical

Gov announces expansion of UK’s ONS COVID-19 survey

Health and Social Care Secretary Matt Hancock has announced plans to expand the Office for National Statistics’ (ONS) infection survey to increase insight into the prevalence and spread of COVID-19.

Under the plans, the survey, which tracks the virus in the general population using routine swabbing and antibody testing, will expand from regularly testing 28,000 people per fortnight in England to 150,000 by October.

The ONS has also partnered with Scotland, Wales and Northern Ireland to extend the scope of the survey across the four nations, making it UK’s largest COVID-19 surveillance survey.

Expanding the survey will play “a crucial role: in providing extensive, weekly data on the spread of infection, supporting rapid testing and diagnosis of the virus both nationally and in areas of concern, the ONS said.

“This country now has the capacity to test for Coronavirus on an unprecedented scale and this ONS survey will be a crucial part of this work – improving our understanding of the rate of infection in the population and how many people have antibodies,” Hancock noted.

“This will allow us to further narrow down the areas potentially affected by local outbreaks and continue our fight to curb the spread ahead of winter.”

The ONS COVID-19 Infection Survey study is part of Pillar 4 of the government’s COVID-19 testing strategy, to conduct UK-wide surveillance testing to learn more about the spread of the virus and support the development of new tests and treatments.

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026